Crossmark

Association between dermatologic adverse events and quality of life in lung cancer patients treated with epidermal growth factor receptor-tyrosine kinase inhibitors

Crossref DOI link: https://doi.org/10.1007/s00520-022-07347-1

Published Online: 2022-09-03

Published Print: 2022-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hsu, Hui-Te

Yu, Chu-Chun

Lee, Yun-Hsiang

Chan, Jui-Chun

Chu, Chia-Yu https://orcid.org/0000-0002-9370-3279
Funding

Funding for this research was provided by:

National Taiwan University Hospital (NTUH 108-N4171)
License Information

Text and Data Mining valid from 2022-09-03

Version of Record valid from 2022-09-03
More Information

Article History

Received: 7 January 2022

Accepted: 24 August 2022

First Online: 3 September 2022

Declarations

:

: Approved by the ethics committee of the National Taiwan University Hospital (20180705RINB).

: All obtained. The patients in this manuscript have given written informed consent to publication of their case details.

: All obtained.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below